Deutsche Märkte öffnen in 1 Stunde 33 Minute

ProPhase Labs, Inc. (PRPH)

NasdaqCM - NasdaqCM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
5,31+0,12 (+2,31%)
Börsenschluss: 04:00PM EDT
5,45 +0,14 (+2,64%)
Nachbörse: 05:31PM EDT

ProPhase Labs, Inc.

711 Stewart Avenue
Suite 200
Garden City, NY 11530
United States
215 345 0919
https://www.prophaselabs.com

Sektor(en)Healthcare
BrancheDiagnostics & Research
Vollzeitmitarbeiter113

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Ted William KarkusChairman & CEO902,2kN/A1959
Mr. Jed A. LatkinChief Operating Officer & Head of Finance DepartmentN/AN/A1974
Mr. Robert A. Morse Jr.Controller, Principal Financial Officer & Principal Accounting OfficerN/AN/A1975
Mr. Sergio MirallesExecutive VP & Chief Information OfficerN/AN/AN/A
Mr. Jason KarkusPresident of Nebula GenomicsN/AN/AN/A
Mr. Kamal ObbadSenior VP and Director of Sales & Marketing - Nebula GenomicsN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Corporate Governance

ProPhase Labs, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.